Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Michael Vincent Meluzio

Vp, Prin. Accounting Officer at Cue Biopharma, Inc. (CUE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $201K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 14SEC CUECue Biopharma, Inc. Sell 1,14447,817 held (−2%) $28.05 $32K -40.4%
Aug 17SEC CUECue Biopharma, Inc. Sell 1,51953,070 held (−3%) $29.37 $45K -43.1%
Aug 17SEC CUECue Biopharma, Inc. Sell 4,10648,964 held (−8%) $30.35 $125K -44.9%
Aug 17SEC CUECue Biopharma, Inc. Sell 348,961 held (−0%) $31.13 $93 -46.3%